Identification of human brain tumour initiating cells
- PMID: 15549107
- DOI: 10.1038/nature03128
Identification of human brain tumour initiating cells
Abstract
The cancer stem cell (CSC) hypothesis suggests that neoplastic clones are maintained exclusively by a rare fraction of cells with stem cell properties. Although the existence of CSCs in human leukaemia is established, little evidence exists for CSCs in solid tumours, except for breast cancer. Recently, we prospectively isolated a CD133+ cell subpopulation from human brain tumours that exhibited stem cell properties in vitro. However, the true measures of CSCs are their capacity for self renewal and exact recapitulation of the original tumour. Here we report the development of a xenograft assay that identified human brain tumour initiating cells that initiate tumours in vivo. Only the CD133+ brain tumour fraction contains cells that are capable of tumour initiation in NOD-SCID (non-obese diabetic, severe combined immunodeficient) mouse brains. Injection of as few as 100 CD133+ cells produced a tumour that could be serially transplanted and was a phenocopy of the patient's original tumour, whereas injection of 10(5) CD133- cells engrafted but did not cause a tumour. Thus, the identification of brain tumour initiating cells provides insights into human brain tumour pathogenesis, giving strong support for the CSC hypothesis as the basis for many solid tumours, and establishes a previously unidentified cellular target for more effective cancer therapies.
Comment in
-
Neurobiology: at the root of brain cancer.Nature. 2004 Nov 18;432(7015):281-2. doi: 10.1038/432281a. Nature. 2004. PMID: 15549078 No abstract available.
Similar articles
-
Insight into the complex regulation of CD133 in glioma.Int J Cancer. 2011 Feb 1;128(3):501-10. doi: 10.1002/ijc.25687. Int J Cancer. 2011. PMID: 20853315 Review.
-
Culture and isolation of brain tumor initiating cells.Curr Protoc Stem Cell Biol. 2009 Oct;Chapter 3:Unit3.3. doi: 10.1002/9780470151808.sc0303s11. Curr Protoc Stem Cell Biol. 2009. PMID: 19816962
-
The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53. doi: 10.1016/j.ejcts.2009.03.063. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464919
-
How powerful is CD133 as a cancer stem cell marker in brain tumors?Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Epub 2009 Apr 14. Cancer Treat Rev. 2009. PMID: 19369008 Review.
-
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature. 2007 Jan 4;445(7123):106-10. doi: 10.1038/nature05372. Epub 2006 Nov 19. Nature. 2007. PMID: 17122772
Cited by
-
Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy.Nat Commun. 2024 May 30;15(1):4616. doi: 10.1038/s41467-024-48214-3. Nat Commun. 2024. PMID: 38816355 Free PMC article.
-
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.Front Immunol. 2024 May 10;15:1389971. doi: 10.3389/fimmu.2024.1389971. eCollection 2024. Front Immunol. 2024. PMID: 38799440 Free PMC article.
-
Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.Front Immunol. 2024 May 3;15:1369356. doi: 10.3389/fimmu.2024.1369356. eCollection 2024. Front Immunol. 2024. PMID: 38765006 Free PMC article. Review.
-
METTL8 links mt-tRNA m3C modification to the HIF1α/RTK/Akt axis to sustain GBM stemness and tumorigenicity.Cell Death Dis. 2024 May 14;15(5):338. doi: 10.1038/s41419-024-06718-2. Cell Death Dis. 2024. PMID: 38744809 Free PMC article.
-
Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells.J Ginseng Res. 2024 May;48(3):266-275. doi: 10.1016/j.jgr.2024.03.003. Epub 2024 Mar 12. J Ginseng Res. 2024. PMID: 38707642 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous